#60 Antipsychotics for depression: An acceptable risk/benefit profile?
CLINICAL QUESTION
Are antipsychotics, either added to standard antidepressants or as monotherapy, effective for the treatment of depression without psychotic features?
BOTTOM LINE
Second-generation antipsychotics appear effective in treating depression when given to augment antidepressants. One antipsychotic (quetiapine) appears effective in treating depression alone but equivalence to antidepressants is uncertain. The evidence has a high risk of bias and adverse events are common.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
2010 Cochrane review1 (28 trials, 8487 patients):
- Antipsychotic versus antidepressant: Equivalence is uncertain.
- Olanzapine (five trials, 779 patients): Two of five olanzapine studies found antidepressants superior (three found no difference).
- Quetiapine (one trial, 309 patients): Equivalent but only one trial.
- Antipsychotic versus placebo: Only quetiapine (four trials, 2,069 patients) was studied in depression without psychosis:
- Response (Number Needed to Treat (NNT)=8) and remission (NNT=17)
- Antipsychotic added to (augmenting) antidepressants: 12 trials using aripiprazole, olanzapine, quetiapine, or risperidone:
- Response (NNT=7-12) and remission (NNT=7-12).
- Adverse events were common, and typical of the antipsychotic studied (example 4 kg weight gain with olanzapine).
- More patients stopped due to adverse events in the antipsychotic group: Number Needed to Harm (NNH)=6-13 when used alone and NNH=12-50 when used as augmentation.
- Insufficient evidence to determine if one antipsychotic is superior to others.
- Trials in systematic reviews have a high risk of bias including unclear allocation concealment, selective reporting and short trial duration (22 of 28 studies <12 weeks)
- Although not assessed, selective publication (not publishing negative studies)6 and sponsorship bias7 are common concerns in the literature.
- Canadian8 and American9 depression guidelines include the option of second-generation antipsychotics alone or as augmentation therapy in patients who have failed first-line antidepressants.
- Efficacy of second-generation antipsychotics is minimal in some anxiety conditions (like Generalized Anxiety Disorder) but may help others (like Obsessive Compulsive Disorder).10
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
Good refresher